Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26074722

Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Sarcoma
Publication date
2015
First author
Dickson MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Dickson MA
      type
      Author
    2. name
      D'Adamo DR
      type
      Author
    3. name
      Keohan ML
      type
      Author
    4. name
      D'Angelo SP
      type
      Author
    5. name
      Carvajal RD
      type
      Author
    6. name
      Gounder MM
      type
      Author
    7. name
      Maki RG
      type
      Author
    8. name
      Qin LX
      type
      Author
    9. name
      Lefkowitz RA
      type
      Author
    10. name
      McKennon OR
      type
      Author
    11. name
      Hirst CM
      type
      Author
    12. name
      Schwartz GK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Dickson MA
      type
      Author
    2. name
      D'Adamo DR
      type
      Author
    3. name
      Keohan ML
      type
      Author
    4. name
      D'Angelo SP
      type
      Author
    5. name
      Carvajal RD
      type
      Author
    6. name
      Gounder MM
      type
      Author
    7. name
      Maki RG
      type
      Author
    8. name
      Qin LX
      type
      Author
    9. name
      Lefkowitz RA
      type
      Author
    10. name
      McKennon OR
      type
      Author
    11. name
      Hirst CM
      type
      Author
    12. name
      Schwartz GK
      type
      Author
    bibliography ids
    1. nci-bib-9b696b3e2922d71e171e35ee
    book metadata
    content sha256
    aefc6687f18c3cf0c080901fdcf6311b29e41c245504a3c0149a94a0c3d1f1f3
    document type
    citation
    dois
    1. 10.1155/2015/532478
    electronic publication date
    display
    2015 May 14
    precision
    day
    year
    2015
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26074722
    immutable id
    pubmed:26074722@aefc6687f18c3cf0c080901fdcf6311b29e41c245504a3c0149a94a0c3d1f1f3
    journal
    abbreviation
    Sarcoma
    issn electronic
    1369-1643
    issn print
    1357-714X
    issue
    Source null
    name
    Sarcoma
    nlm unique id
    9709257
    pages
    532478
    volume
    2015
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26074722
      provenance
      batch id
      74265f1b641f04cf2d05
      provider
      NCBI PubMed ESummary
      record sha256
      1cc2458da9a6559fec48c2ff2d8d085063c5f2b29437c8568c9de1ea4ed72d78
      response sha256
      193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
      retrieved at
      2026-09-09T23:47:10.134322+00:00
      publication date
      display
      2015
      precision
      year
      year
      2015
      publication types
      1. Journal Article
      record status
      PubMed
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26074722/
      title
      Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma.

      Preserved source evidence · Not medical advice